FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Sunbeam Management, LLC 2. Date of Event Requiring Statement (MM/DD/YYYY)
3/23/2020 

3. Issuer Name and Ticker or Trading Symbol OWC Pharmaceutical Research Corp. [OWCP]
(Last)       (First)       (Middle)
8402 TOPPING ROAD
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)
PIKESVILLE, MD 21208      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock  500000  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Convertible Preferred Stock  3/23/2020  1/1/2030  Sunbeam Management, LLC  43675  $0  D   

Explanation of Responses:

Remarks:
Conversion rights do not have an expiration date. Expiration date provided for filing purposes only.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Sunbeam Management, LLC
8402 TOPPING ROAD
PIKESVILLE, MD 21208

X


Signatures
Jeffrey Low 5/11/2020
**Signature of Reporting Person Date
OWC Pharmaceuticals Rese... (PK) (USOTC:OWCP)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more OWC Pharmaceuticals Rese... (PK) Charts.
OWC Pharmaceuticals Rese... (PK) (USOTC:OWCP)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more OWC Pharmaceuticals Rese... (PK) Charts.